Mark Tristan Quimque

6PUBLICATIONS
17CO-AUTHORS
Innate immunityGlycoconjugatesNanotoxicology, health and safetyCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 23, 2023
Attenuation of Lipopolysaccharide-Induced Inflammatory Responses through Inhibition of the NF-κB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n-Butanol Fraction from Uvaria alba.

Kin Israel R Notarte, Mark Tristan J Quimque, Imee T Macaranas

|Oct 24, 2022
Polyoxygenated Cyclohexenes from Uvaria grandiflora with Multi-Enzyme Targeting Properties Relevant in Type 2 Diabetes and Obesity.

Mark Tristan J Quimque, Ryan Joseph Y Magsipoc, Lloyd Christian J Llames

|Oct 04, 2021
Computational and Experimental Assessments of Magnolol as a Neuroprotective Agent and Utilization of UiO-66(Zr) as Its Drug Delivery System.

Joshua Santos, Mark Tristan Quimque, Rhenz Alfred Liman

|Aug 31, 2021
Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.

Rey Arturo Fernandez, Mark Tristan Quimque, Kin Israel Notarte

|Jul 01, 2021
Catechol-Bearing Polyketide Derivatives from Sparticola junci.

Katherine Yasmin M Garcia, Chayanard Phukhamsakda, Mark Tristan J Quimque

|Jun 02, 2020
Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms.

Mark Tristan J Quimque, Kin Israel R Notarte, Rey Arturo T Fernandez

Pageof 1

Frequent Collaborators

6 joint publications

Allan Patrick G Macabeo

2 joint publications

Oliver B Villaflores

1 joint publications

Katherine Yasmin M Garcia

1 joint publications

Chayanard Phukhamsakda